WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1993020824) PHARMACEUTICAL COMPOSITIONS CONTAINING MONOSIALOGANGLIOSIDE DERIVATIVES SUITABLE FOR THE TREATMENT OF SPINAL CORD INJURY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1993/020824    International Application No.:    PCT/EP1993/000894
Publication Date: 28.10.1993 International Filing Date: 13.04.1993
Chapter 2 Demand Filed:    04.11.1993    
IPC:
A61K 31/70 (2006.01)
Applicants: FIDIA S.P.A. [IT/IT]; Via Ponte della Fabbrica, 3/A, I-35031 Abano Terme (IT) (For All Designated States Except US).
ROMEO, Aurelio [IT/IT]; (IT) (For US Only).
TOFFANO, Gino [IT/IT]; (IT) (For US Only)
Inventors: ROMEO, Aurelio; (IT).
TOFFANO, Gino; (IT)
Agent: GERVASI, Gemma; Notarbartolo & Gervasi S.r.L., Viale Bianca Maria, 33, I-20122 Milano (IT)
Priority Data:
MI92A000878 10.04.1992 IT
Title (EN) PHARMACEUTICAL COMPOSITIONS CONTAINING MONOSIALOGANGLIOSIDE DERIVATIVES SUITABLE FOR THE TREATMENT OF SPINAL CORD INJURY
(FR) COMPOSITIONS PHARMACEUTIQUES CONTENANT DES DERIVES DE MONOSIALOGANGLIOSIDE POUVANT ETRE UTILISEES POUR TRAITER DES LESIONS DE LA MOELLE EPINIERE
Abstract: front page image
(EN)Pharmaceutical compositions containing monosialoganglioside derivatives suitable for the treatment of spinal cord injury caused by hypoxic-ischaemic or traumatic events, in which said derivatives are selected from the group consisting of the inner ester (AGF¿2?) and the methyl ester (AGF¿4?) of the monosialoganglioside (GM¿1?).
(FR)Compositions pharmaceutiques renfermant des dérivés de monosialoganglioside pouvant être utilisées pour traiter des lésions de la moelle épinière provoquées par des accidents hypoxiques-ischémiques ou traumatiques. Lesdits dérivés sont sélectionnés dans le groupe formé par l'ester interne (AGF¿2?) et l'ester de méthyle (AGF¿4?) du monosialoganglioside (GM¿1?).
Designated States: AU, BB, BG, BR, CA, CZ, FI, HU, JP, KP, KR, KZ, LK, MG, MN, MW, NO, NZ, PL, RO, RU, SD, SK, UA, US, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)